Genesis Capital back in clinical research with Crux Biolabs deal
It has cut a deal to take a controlling stake in the business, and existing owner Leading Technology Group will retain a minority position.
Source: afr.com
Page 5 - Nucleus Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nucleus Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nucleus Network Today - Breaking & Trending Today
Blackstone chews on Zambrero as strategic review awaits
It’s burritos all round in Blackstone’s private equity unit, as the group’s team runs the numbers on Australian born-and-bred fast food chain Zambrero.
Source: afr.com
Odyssey Health, Inc. Announces Positive Results from Initial Phase I Clinical Trial Subjects for Concussion Drug
Irvine, CA, May 05, 2022 -- Odyssey Health, Inc. , f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-saving medical products, today announced positive results... | May 5, 2022
Source: marketscreener.com
A Guide to Preclinical and CMC Requirements for Conducting Clinical Trials in Australia, Upcoming Webinar Hosted by Xtalks
Toronto, ON (PRWEB) April 11, 2022 -- Sponsors are increasingly interested in conducting early phase clinical trials in Australia. This is because of
Source: prweb.com
Monash University poised to leverage proximity to Moderna's mRNA facility
Melbourne already has the researchers and the expertise in running drug trials ready to work with the pharma multinational.
Source: afr.com